The vector of anti-TERT T cell receptor (TCR) is constructed for the engineering of T cell to target Human TERT. The T cells are genetically modified through transduction with a lentiviral vector expressing TERT-specific T cell receptor. And the vector product was designed for the treatment of Alzheimer's disease.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C519||Lenti-TERT T cell receptor (ILA1β2) Viral Particle|
|TCR-L112||Human anti-TERT (VYGFVRACL) T Cell Receptor, pGMT7|
|TCR-L112Z||Human anti-telomerase catalytic subunit protein (aa461-469) T cell receptor (Cysteine-modiﬁed), pCDTCR1|
|VP-TCR-C522||Lenti-telomerase catalytic subunit protein T cell receptor (Cysteine-modiﬁed) Viral Particle|
|VP-TCR-C520||Lenti-TERT T cell receptor Viral Particle|
|VP-TCR-C521||Lenti-telomerase catalytic subunit protein T cell receptor Viral Particle|
|TCR-L111Z||Human anti-telomerase catalytic subunit protein (aa461-469) T cell receptor, pCDTCR1|
|TCR-C246Z||Human anti-TERT T cell receptor (ILA1β2), pCDTCR1|
|TCR-L113||Human anti-TERT (VYGFVRACL) T Cell Receptor[Cysteine-modiﬁed], pGMT7|
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved